| 1 | 1610-04-4 | 2-BROMO-2,2-DIFLUORO-1-PHENYL-ETHANONE | C8H5BrF2O | 235.03 | | |
| 2 | 1610-13-5 | 1-ethynylcyclopent-1-ene | C7H8 | 92.14 | 101-102 °C(Solv: benzene (71-43-2); hexane (110-54-3)) | |
| 3 | 1610-17-9 | 2-Methoxyacrazine | C9H17N5O | 211.26 | | 1.67g/L(25 ºC) |
| 4 | 1610-18-0 | PROMETON | C10H19N5O | 225.29 | 118-121℃ | 0.75g/L(21 ºC) |
| 5 | 1610-22-6 | 1,2,3,4,4a,7,8,9,10,11,12,12a-Dodecahydrochrysene | C18H24 | 240.38 | | |
| 6 | 1610-23-7 | 1,6-Dicyclohexylhexane | C18H34 | 250.46 | 8.6°C | |
| 7 | 1610-24-8 | Tricyclohexylmethane. | C19H34 | 262.47 | 48°C | |
| 8 | 1610-29-3 | 2-methylpent-2-en-1-ol | C6H12O | 100.16 | 22.55°C (estimate) | |
| 9 | 1610-33-9 | PHOSPHONIC ACID, ETHYL METHYL ESTER | C3H9O3P | 124.08 | | |
| 10 | 1610-39-5 | Dodecahydrotriphenylene | C18H24 | 240.38 | 231-233 °C (lit.) | |
| 11 | 1610-51-1 | Tricyclo[6.2.0.03,6]deca-1,3(6),7-triene | C10H10 | 130.19 | 98-100 °C | |
| 12 | 1610-52-2 | 11,20-dioxo-5-beta-pregnan-3-alpha-yl acetate | C23H34O4 | 374.51 | | |
| 13 | 1610-68-0 | 2-(4-Chlorobenzyl)-3-(4-chlorophenyl)propionic acid | C16H14Cl2O2 | 309.19 | 124-126℃ | |
| 14 | 16100-06-4 | 4-Chloro-7-chloro-2,1,3-benzooxadiazole | C6H2Cl2N2O | 189 | | |
| 15 | 16100-81-5 | 5,5-Dichloroquinolin-6(5H)-one | C9H5Cl2NO | 214.05 | 58 °C | |
| 16 | 16100-84-8 | Dihydroperaksine | C19H24N2O2 | 312.41 | | |
| 17 | 16100-91-7 | 2H-Quinolizine-1-carboxylic acid, octahydro-, ethyl ester, (1R-trans)- (9CI) | C12H21NO2 | 211.3 | | |
| 18 | 16100-92-8 | (1R,9aR)-Octahydro-2H-quinolizine-1-carboxylic acid hydrochloride | C10H18ClNO2 | 219.70842 | 242-244 °C | |
| 19 | 1610007-47-0 | D-Glucitol, 1,5-anhydro-1-C-[5-(2-azulenylmethyl)-2-hydroxyphenyl]-, compd. with 2-hydroxy-N,N,N-trimethylethanaminium inner salt (1:1) | C28H37NO7 | 499.6 | | |
| 20 | 1610007-63-0 | 6-iodo-3-methyl-2-(trifluoromethyl)imidazo[1,2-b]pyridazine | | | | |
| 21 | 1610007-64-1 | Imidazo[1,2-b]pyridazine, 6-ethenyl-3-methyl-2-(trifluoromethyl)- | C10H8F3N3 | 227.19 | | |
| 22 | 1610007-65-2 | Imidazo[1,2-b]pyridazine-6-carboxaldehyde, 3-methyl-2-(trifluoromethyl)- | C9H6F3N3O | 229.16 | | |
| 23 | 1610008-14-4 | 6-chloro-2-methylimidazo[1,2-b]pyridazine-3-carbaldehyde | C8H6ClN3O | 195.61 | | |
| 24 | 1610008-47-3 | 1610008-47-3 | C5H3ClF3N3 | 197.55 | | |
| 25 | 1610008-51-9 | 6-chloro-4-isopropylpyridazin-3-amine | C7H10ClN3 | 171.63 | | |
| 26 | 1610008-65-5 | 6-chloro-3,8-dimethyl-2-(trifluoromethyl)imidazo[1,2-b]pyridazine | | | | |
| 27 | 1610008-77-9 | 3-Pyridazinamine, 6-chloro-5-methoxy- | C5H6ClN3O | 159.57 | | |
| 28 | 1610008-84-8 | Imidazo[1,2-b]pyridazine-2-carboxylic acid, 6-iodo-3-methyl-, methyl ester | | 317.08 | | |
| 29 | 161001-61-2 | L-Asparagine, N2-[(1,1-dimethylethoxy)carbonyl]-N-(triphenylmethyl)-, methyl ester | C29H32N2O5 | 488.57 | | |
| 30 | 161001-96-3 | phenoxycarbonyltetrazole | | | | |
| 31 | 1610010-57-5 | Suvemcitug | | | | |
| 32 | 1610010-60-0 | Varisacumab | | | | |
| 33 | 1610014-47-5 | Propanedioic acid, 2-(4-aminobutyl)-, 1,3-diethyl ester | C11H21NO4 | 231.29 | | |
| 34 | 1610016-88-0 | 3-Pyridinecarboxamide, 6-(6-benzothiazolylamino)-4-(cyclopropylamino)-N-[(2R)-2-fluoro-3-hydroxy-3-methylbutyl]- | C21H24FN5O2S | 429.51 | | |
| 35 | 1610017-20-3 | 3-Pyridinecarboxamide, 4-(cyclopropylamino)-N-[(2R)-2-fluoro-3-hydroxy-3-methylbutyl]-6-(1,6-naphthyridin-2-ylamino)- | C22H25FN6O2 | 424.47 | | |
| 36 | 1610021-22-1 | Imidazo[1,2-b]pyridazin-6-amine, 3-methyl- | C7H8N4 | 148.17 | | |
| 37 | 1610021-24-3 | Pyrazolo[1,5-a]pyridin-5-amine, 3-fluoro- | C7H6FN3 | 151.14 | | |
| 38 | 1610021-26-5 | Pyrazolo[1,5-a]pyridin-5-amine, 3-chloro- | C7H6ClN3 | 167.6 | | |
| 39 | 1610021-29-8 | 5-Fluoro-2-methylbenzo[d]thiazol-6-amine | C8H7FN2S | 182.22 | | |
| 40 | 1610021-30-1 | 3-Fluoropyrazolo[1,5-a]pyrimidin-5-amine | C6H5FN4 | 152.13 | | |
| 41 | 1610021-31-2 | Pyrazolo[1,5-a]pyrimidin-5-amine, 3-chloro- | C6H5ClN4 | 168.58 | | |
| 42 | 1610021-32-3 | 5-Bromo-2-methylpyrazolo[1,5-a]pyrimidine | C7H6BrN3 | 212.05 | | |
| 43 | 1610021-35-6 | Pyrazolo[1,5-a]pyrimidin-7-amine, 5-chloro-6-fluoro- | C6H4ClFN4 | 186.57 | | |
| 44 | 1610021-36-7 | 5-chloro-6-fluoropyrazolo[1,5-a]pyrimidine | C6H3ClFN3 | 171.56 | | |
| 45 | 1610021-60-7 | 5-Chloro-6-methylpyrazolo[1,5-a]pyrimidine | | | | |
| 46 | 1610021-97-0 | Pyrazolo[1,5-a]pyrimidin-5-amine, 6-fluoro- | C6H5FN4 | 152.13 | | |
| 47 | 1610022-76-8 | Nrf2 inhibitor 1 | C21H22ClN3O2 | 383.87 | | |
| 48 | 1610027-87-6 | 1-(4-Bromophenyl)cycloheptanol | C13H17BrO | 269.18 | | |
| 49 | 1610027-90-1 | 5-Bromo-2-fluoro-4-trifluoromethyl-pyridine | C6H2BrF4N | 243.98 | | |
| 50 | 1610028-25-5 | 2-(3-oxocyclobutyl)acetic acid | C6H8O3 | 128.12592 | | |
| 51 | 1610028-38-0 | 4-Methylpent-3-enoic acid, sodiuM salt | C6H9NaO2 | 136.12423 | | |
| 52 | 1610028-39-1 | 2,3-Dihydro-1H-pyrrolo[2,3-c]pyridine hydrochloride | C7H9ClN2 | 156.61276 | | |
| 53 | 1610028-40-4 | 3-(3-Methoxyphenyl)pyrrolidine oxalate(2:1) | C24H32N2O6 | 444.52 | | |
| 54 | 1610028-41-5 | tert-Butyl Methyl(pyrrolidin-3-yl)carbaMate hydrochloride | C10H21ClN2O2 | 236.73894 | | |
| 55 | 1610028-42-6 | 2-Methyl-2,7-diazaspiro[3.5]nonane dihydrochloride | C8H18Cl2N2 | 213.14792 | | |
| 56 | 1610028-43-7 | 6-(AMinoMethyl)picolinic acid hydrochloride | C7H9ClN2O2 | 188.61156 | | |
| 57 | 1610029-17-8 | (E)-methyl 7-((1R,2R,3R,5S)-5-acetoxy-2-((E)-4,4-difluoro-3-oxooct-1-en-1-yl)-3-((tetrahydro-2H-pyran-2-yl)oxy)cyclopentyl)hept-2-enoate | C28H42F2O7 | 528.6256864 | | |
| 58 | 1610029-53-2 | Bisphenol A-d6 β-D-Glucuronide | C21H24O8 | 404.42 | | |
| 59 | 161003-28-7 | 2,3:5,6-DI-O-ISOPROPYLIDENE-4-(TETRAHYDROPYRAN-2-YL)-MYO-INOSITOL | C17H28O7 | 344.4 | | |
| 60 | 1610033-01-6 | 1,2-Pyrrolidinedicarboxylic acid, 4-hydroxy-4-(trifluoromethyl)-, 1-(1,1-dimethylethyl) 2-(phenylmethyl) ester, (2R)- | C18H22F3NO5 | 389.37 | | |
| 61 | 1610033-20-9 | ((2R,4R)-4-methoxypyrrolidin-2-yl)methanol hydrochloride | C6H14ClNO2 | 167.63386 | | |
| 62 | 1610034-33-7 | ((R)-4,4-dimethylpyrrolidin-2-yl)methanol | C7H15NO | 129.2 | | |
| 63 | 1610035-55-6 | tert-butyl cis-4-hydroxy-3-(hydroxymethyl)piperidine-1-carboxylate | C11H21NO4 | 231.28874 | | |
| 64 | 1610035-92-1 | (2R,3R)-1-Boc-3-methyl-pyrrolidine-2-carboxylic acid | C11H19NO4 | 229.27 | | |
| 65 | 1610036-44-6 | O1-tert-butyl O2-methyl (2R,4S)-4-benzyloxypyrrolidine-1,2-dicarboxylate | C18H25NO5 | 335.39 | | |
| 66 | 161004-98-4 | thieno[3,2-b]pyridin-5-ylmethanol | C8H7NOS | 165.21 | | |
| 67 | 1610043-62-3 | 1-(5-(2-fluorophenyl)-1H-pyrrol-3-yl)-N-methylmethanamine | C12H13FN2 | 204.24 | | |
| 68 | 1610043-63-4 | [[5-(2-fluorophenyl)-1H-pyrrol-3-yl]methyl]-N-methyl-Carbamicacid-1,1-dimethylethyl ester | C17H21FN2O2 | 304.36 | | |
| 69 | 1610043-75-8 | Cyclopropanecarboxylic acid, 1-[(methylamino)carbonyl]-, methyl ester | C7H11NO3 | 157.17 | | |
| 70 | 1610043-76-9 | 1-(HYDROXYMETHYL)-N-METHYLCYCLOPROPANECARBOXAMIDE | C6H11NO2 | 129.16 | | |
| 71 | 1610044-98-8 | 1,2,4-Triazolo[4,3-a]pyrazin-8-amine, N,3-dimethyl-6-[6-(4-methyl-1-piperazinyl)-1-(phenylmethyl)-1H-benzimidazol-2-yl]- | C26H29N9 | 467.57 | | |
| 72 | 1610045-39-0 | 6-BROMO-8-CHLORO-3-METHYL-[1,2,4]TRIAZOLO[4,3-A]PYRAZINE | C6H4BrClN4 | 247.48 | | |
| 73 | 1610045-42-5 | 6-bromo-N,3-dimethyl-[1,2,4]triazolo[4,3-a]pyrazin-8-amine | C7H8BrN5 | 242.08 | | |
| 74 | 1610046-78-0 | #N/A | | | | |
| 75 | 1610047-06-7 | Butanediamide, N1,N4-bis[(3R)-1-[3-[(2-cyanophenyl)methyl]-1,2,3,6-tetrahydro-1-methyl-2,6-dioxo-4-pyrimidinyl]-3-piperidinyl]- | C40H44N10O6 | 760.84 | | |
| 76 | 161005-84-1 | (S)-N,N-DIMETHYL-[3-(2-THIENYL)-3-(1-NAPHTHYLOXY)PROPYL]AMINE--PHOSPHORIC ACID (1:1) | C19H24NO5PS | 409.44 | | |
| 77 | 1610050-61-7 | "2-{2-[5-(4-Diphenylamino-phenyl)-thieno[3,2-b]thiophen-2-yl]-thiazol-5-ylmethylene}-malononitrile | C31H18N4S3 | 542.7 | | |
| 78 | 1610054-32-4 | 5-Methyl-N-[4-(4-methyl-1-piperazinyl)phenyl]-4-(4,5,6,7-tetrahydrofuro[3,2-c]pyridin-2-yl)-2-pyrimidinamine | C23H28N6O | 404.52 | | |
| 79 | 1610054-34-6 | N-[4-(4-methyl-1-piperazinyl)phenyl]-4-[4,5,6,7-tetrahydro-5-(phenylmethyl)furo[3,2-c]pyridin-2-yl]-2-Pyrimidinamine | C29H32N6O | 480.6 | | |
| 80 | 1610054-35-7 | N-[4-(4-Ethyl-1-piperazinyl)phenyl]-5-methyl-4-[4,5,6,7-tetrahydro-5-(phenylmethyl)furo[3,2-c]pyridin-2-yl]-2-pyrimidinamine | C31H36N6O | 508.67 | | |
| 81 | 1610054-41-5 | 1,1-Dimethylethyl 4-[4-[[4-[4,5,6,7-tetrahydro-5-[(4-methoxyphenyl)methyl]furo[3,2-c]pyridin-2-yl]-5-(trifluoromethyl)-2-pyrimidinyl]amino]phenyl]-1-piperazinecarboxylate | C35H39F3N6O4 | 664.73 | | |
| 82 | 1610054-42-6 | N-[4-(4-Ethyl-1-piperazinyl)phenyl]-4-(4,5,6,7-tetrahydrofuro[3,2-c]pyridin-2-yl)-5-(trifluoromethyl)-2-pyrimidinamine | C24H27F3N6O | 472.52 | | |
| 83 | 1610056-01-3 | Peptide T TFA | C37H56F3N9O18 | 971.89 | | |
| 84 | 1610056-71-7 | Sodium Methanesulfonate-d3 | | | | |
| 85 | 1610057-05-0 | 2,3-Bis-(5-trimethylstannanyl-thiophen-2-yl)-acrylonitrile | C17H23NS2Sn2 | 542.92 | | |
| 86 | 1610057-24-3 | 1,2-Bis(5-(trimethylstannyl)thiophen-2-yl)ethyne | C16H22S2Sn2 | 515.9 | | |
| 87 | 1610059-51-2 | 1,3-Benzenedicarboxylic acid, 5-[4,2':6',4''-terpyridin]-4'-yl- | C23H15N3O4 | 397.38 | | |
| 88 | 161006-14-0 | 10-methyl-9-(phenoxycarbonyl) Acridinium (trifluoromethylsulfonate) | C22H16F3NO5S | 463.4263496 | 228-230 °C | |
| 89 | 161006-18-4 | 3-[[(1,1-DIMETHYLETHYL)DIMETHYLSILYL]OXY]-PHENOL | C12H20O2Si | 224.37 | | |
| 90 | 161006-22-0 | 2-Naphthalenol, 6-[[(1,1-dimethylethyl)dimethylsilyl]oxy]- | C16H22O2Si | 274.43 | | |
| 91 | 1610060-53-1 | 2-Bromo-6-fluoro-3-nitro-benzoic acid methyl ester | C8H5BrFNO4 | 278.03 | | |
| 92 | 1610060-59-7 | 2-bromo-6-fluoro-4-nitrobenzoic acid | C7H3BrFNO4 | 264.0054232 | | |
| 93 | 161007-96-1 | 4-Methylphenyl 4,6-O-benzylidene-1-thio-b-D-galactopyranoside | C20H22O5S | 374.45 | 163-164°C | |
| 94 | 16101-08-9 | 9-methoxy-1,5-dimethyl-6H-pyrido[4,3-b]carbazole | C18H16N2O | 276.33 | 291-293 °C | |
| 95 | 16101-11-4 | (+)-2,3,4,6-tetrahydro-9-methoxy-1,2,5-trimethyl-1H-pyrido[4,3-b]carbazole | C19H22N2O | 294.39 | | |
| 96 | 16101-12-5 | 20,21-Dihydro-21-methyl-18-noralstphyllan-19-ol | C21H28N2O2 | 340.46 | | |
| 97 | 16101-29-4 | 1-Phenazinol,1,2,3,4-tetrahydro-, 1-acetate, 5-oxide | C14H14N2O3 | 258.27256 | | |
| 98 | 16101-49-8 | 1-chloro-7,8-dimethoxyisoquinoline | C11H10ClNO2 | 223.66 | | |
| 99 | 16101-63-6 | 6,7-DIMETHOXY-1(2H)-ISOQUINOLONE | C11H11NO3 | 205.21 | | |
| 100 | 16101-90-9 | 5-MERCAPTO-4-PHENYL-3H-1,2-DITHIOLE-3-THIONE | C9H6S4 | 242.4 | 153 °C | |
| 101 | 161010-26-0 | Hydrazinecarboxylic acid, 2-(aminocarbonyl)-2-(1-methylethyl)-, methyl ester | C6H13N3O3 | 175.19 | | |
| 102 | 161010-39-5 | 2,4-Thiazolidinedione, 5-[[4-[2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy]-1-naphthalenyl]methyl]- | C26H22N2O4S | 458.53 | | |
| 103 | 161011-36-5 | LZLCNYLUGBHBQW-UHFFFAOYSA-N | C11H22O2 | 186.29 | | |
| 104 | 161011-72-9 | Sulfo-BSOCOES | C14H16N2O18S3 | 596.47 | | |
| 105 | 161012-10-8 | HCV-1 E2 PROTEIN (484-499) | C88H122N20O19S2 | 1828.16 | | |
| 106 | 161012-67-5 | N-butylcycloheptanamine | C11H23N | 169.31 | | |
| 107 | 161012-98-2 | Thiazole, 4-ethoxy-5-methyl-2-phenyl- (9CI) | C12H13NOS | 219.3 | | |
| 108 | 161013-20-3 | 5-(2-BROMOPHENYL)-1,3,4-OXADIAZOLE-2(3H)-THIONE | C8H5BrN2OS | 257.11 | | |
| 109 | 161014-15-9 | 1-(Tetrahydro-2H-pyran-2-yl)-1H-iMidazole | C8H12N2O | 152.19368 | | |
| 110 | 161014-17-1 | 1H-Imidazole,2-fluoro-1-(methoxymethyl)-(9CI) | C5H7FN2O | 130.1202832 | | |
| 111 | 161014-18-2 | 1H-Imidazole,1-(methoxymethyl)-2-methyl-(9CI) | C6H10N2O | 126.16 | | |
| 112 | 161014-55-7 | Tiagabine Impurity 6 | C20H25NO3S2 | 391.55 | | |
| 113 | 161014-56-8 | Keto Tiagabine Tosylate | C27H33NO6S3 | 563.75 | | |
| 114 | 161016-50-8 | β-D-Glucopyranoside, (1R,2S,4aR,4bR,6'S,6aR,7R,8S,10aR,10bR,12aS)-7-[(β-D-glucopyranosyloxy)methyl]octadecahydro-1-hydroxy-6'-[(1S)-2-hydroxy-1-methylethyl]-4a,4b,7,10a-tetramethylspiro[chrysene-2(1H),3'(4'H)-[2H]pyran]-8-yl 2-O-β-D-xylopyranosyl- | C47H80O19 | 949.13 | | |
| 115 | 161016-51-9 | Hosenkoside M | C53H90O24 | 1111.28 | | |
| 116 | 161016-52-0 | β-D-Glucopyranoside, (1R,2S,4aR,4bR,6aS,7R,8R,10aR,10bR,12aR)-1-[(β-D-glucopyranosyloxy)methyl]octadecahydro-7-hydroxy-8-(hydroxymethyl)-1,4a,10a,10b-tetramethyl-8-(4-methyl-3-pentenyl)-2-chrysenyl 2-O-β-D-glucopyranosyl- (9CI) | C48H82O19 | 963.15 | | |
| 117 | 161016-55-3 | PO-PRO 3 | C22H29I2N3O | 605.29 | >250℃ | |
| 118 | 161016-93-9 | (2R,3R,4S,5R)-2-(6-Amino-9H-purin-9-yl)-5-(hydroxymethyl)-4-((6-(tritylthio)hexyl)oxy)tetrahydrofuran-3-ol | C35H39N5O4S | 625.78 | | |
| 119 | 161016-97-3 | 9,19-Cyclocholesta-7,20-diene-3,14,18-triol,(3b,5a)- (9CI) | C27H42O3 | 414.62058 | | |
| 120 | 161017-23-8 | 2-Pyrrolidinebutanoicacid, a-[[4-O-(2-amino-2-deoxy-b-D-gulopyranosyl)-a-D-galactopyranosyl]oxy]-b,g,3,4-tetrahydroxy-5-(hydroxymethyl)-, (aR,bS,gS,2S,3S,4S,5S)- (9CI) | C21H38N2O17 | 590.52962 | | |
| 121 | 16102-24-2 | dicyclopropyldiazomethane | C7H10N2 | 122.1677 | | |
| 122 | 16102-50-4 | Nsc117618 | C17H14O2 | 250.29186 | | |
| 123 | 16102-85-5 | 1,3,5,7,2,4,6,8-Tetrazatetraphosphocine, 2,2,4,4,6,6,8,8-octahydro-2,2,4,4,6,6,8,8-octakis(4-nitrophenoxy)- (9CI) | C48H32N12O24P4 | 1284.73 | | |
| 124 | 16102-94-6 | Olivenite (Cu2(AsO4)(OH)) | | | | |
| 125 | 16102-99-1 | disodium 1-amino-9,10-dihydro-9,10-dioxo-4-[[4-[[2-(sulphonatooxy)ethyl]sulphonyl]phenyl]amino]anthracene-2-sulphonate | C22H16N2Na2O11S3 | 626.54378 | | |
| 126 | 161022-24-8 | Cyclo[β-alanyl-L-leucyl-ψ(CH2-NH)-L-leucyl-L-glutaminyl-L-tryptophyl-L-phenylalanyl] (9CI) | C40H56N8O6 | 744.92 | | |
| 127 | 161022-52-2 | 4H-1-Benzopyran-4-one, 3-(2,4-dihydroxyphenyl)-2,3-dihydro-7-hydroxy-6,8-bis(3-methyl-2-buten-1-yl)- | C25H28O5 | 408.49 | | |
| 128 | 161024-43-7 | (-)-Lentiginosine | C8H15NO2 | 157.21 | | |
| 129 | 161024-80-2 | (R)-N-BOC-3-Amino-3-phenylpropanoic acid | C14H19NO4 | 265.31 | 123.4 °C | |
| 130 | 161025-21-4 | AlcoholsC12-16C12-15-richethoxylated | | | | |
| 131 | 161025-22-5 | AlcoholsC10-16C12-13-richethoxylated | | | | |
| 132 | 161025-24-7 | Fatty acids, C18-unsatd., dimers, hydrogenated, diisooctadecyl esters | | | | |
| 133 | 161025-83-8 | 3,6-Methano-1H-furo[3,4-b]pyrrole(9CI) | C7H5NO | 119.12 | | |
| 134 | 161026-74-0 | HLA-B73 antigen | | | | |
| 135 | 161026-82-0 | desmocollin type 3 | | | | |
| 136 | 161029-97-6 | 2-Methoxy-3-nitro-6-phenylpyridine | C12H10N2O3 | 230.22 | | |
| 137 | 16103-04-1 | 6-(4-(4-diazonioanilino)phenylazo)-4-ethoxytoluene-3-diazonium zinc chloride | C21H24Cl5N7OZn | 633.11656 | | |
| 138 | 16103-51-8 | N-isopropyl-4-hydroxymethylbenzamide | C11H15NO2 | 193.24 | | |
| 139 | 16103-76-7 | 17,20-[Oxy[(R)-hydroxymethylene]]-20-deethylidene-1,4,21α-trimethylsarpagan-4-ium | C21H27N2O2+ | 339.46 | | |
| 140 | 161030-10-0 | 2-Pyridinecarboxylicacid,5,6-dimethyl-3-nitro-,methylester(9CI) | C9H10N2O4 | 210.19 | | |
| 141 | 161030-11-1 | Benzoic acid, 4-amino-3-methyl-2-nitro-, methyl ester (9CI) | C9H10N2O4 | 210.19 | | |
| 142 | 161032-48-0 | [1,1':3',1''-Terphenyl]-2'-amine, 5'-(1,1-dimethylethyl)- (9CI) | C22H23N | 301.42 | | |
| 143 | 161034-44-2 | Methanimidamide,
N-[(1Z)-2-amino-1,2-dicyanoethenyl]-N'-(4methoxyphenyl) | C12H11N5O | 241.24864 | | |
| 144 | 161034-61-3 | Pyrido[3,4-d]pyridazine, 1,2,3,4-tetrahydro- (9CI) | C7H9N3 | 135.17 | | |
| 145 | 1610346-16-1 | 1H-Pyrazol-5-amine, 4-methyl-3-(2-methyl-5-pyrimidinyl)-1-phenyl- | C15H15N5 | 265.31 | | |
| 146 | 1610346-46-7 | 1-methyl-1,2,3,4-tetrahydroquinolin-4-amine dihydrochloride | C10H15ClN2 | 198.69 | | |
| 147 | 1610347-46-0 | 1610347-46-0 | C12H17NO | 191.27 | | |
| 148 | 1610347-47-1 | 1-amino-4,4-dimethyl-1,2,3,4-tetrahydronaphthalen-2-ol | C12H17NO | 191.27 | | |
| 149 | 161035-23-0 | L-Cystine, N,N'-bis(1-oxo-2-propen-1-yl)- | C12H16N2O6S2 | 348.4 | 115-121 °C(Solv: acetone (67-64-1); ethyl ether (60-29-7)) | |
| 150 | 161035-86-5 | 2H-Benzimidazol-2-one,1,3-dihydro-,(1-methylethylidene)hydrazone(9CI) | C10H12N4 | 188.23 | | |
| 151 | 161035-88-7 | 2H-Benzimidazol-2-one,1,3-dihydro-,methylhydrazone(9CI) | C8H10N4 | 162.19 | | |
| 152 | 1610350-91-8 | Phospho-L-TyrosineDisodiumSalt | C9H13NNaO6P | 285.17 | | |
| 153 | 1610351-01-3 | rac-(1R,3aR,6aS)-2-[(tert-butoxy)carbonyl]-octahydrocyclopenta[c]pyrrole-1-carboxylic acid | C13H21NO4 | 255.31 | | |
| 154 | 1610353-18-8 | Brazikumab | | | | |
| 155 | 1610354-57-8 | 4-amino-3-bromo-1-methylpyridin-2(1H)-one | C6H7BrN2O | 203.04 | | |
| 156 | 1610356-29-0 | Bis (2,2'-bipyridyl) (2,2'-bipyrazine [5,10] phenyl) dichlorate | C36H26ClN8O4Ru+ | 771.18 | | |
| 157 | 1610358-53-6 | (±)-BAY-1251152 | C19H18F2N4O2S | 404.43 | | |
| 158 | 1610358-56-9 | (+)-BAY-1251152 | C19H18F2N4O2S | 404.43 | | |
| 159 | 1610358-59-2 | (-)-BAY-1251152 | C19H18F2N4O2S | 404.44 | | |
| 160 | 1610359-25-5 | Pyridine, 2-chloro-4-(2-ethoxy-4-fluorophenyl)-5-fluoro- | C13H10ClF2NO | 269.68 | | |
| 161 | 1610359-30-2 | 6-(5-(1,2-dithiolan-3-yl)pentanamido)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)hexyl (2-cyanoethyl) diisopropylphosphoramidite | C45H64N3O6PS2 | 838.12 | | |
| 162 | 161036-56-2 | REF DUPL: 3-phenyl-1-adamantaneacetic acid | C18H22O2 | 270.37 | | |
| 163 | 161036-96-0 | Yttrium oxide (Y3O) | H2OY | 106.92 | | |
| 164 | 161036-97-1 | Yttrium oxide (Y4O) | H2OY | 106.92 | | |
| 165 | 1610362-05-4 | 1-[(1,3-BENZODIOXOL-5-YLAMINO)CARBONYL]-2-PYRROLIDINECARBOXYLIC ACID | C13H14N2O5 | 278.26 | | |
| 166 | 1610362-93-0 | 3-Pyridinemethanol, 6-[(3-aminopropyl)amino]-, 1-oxide, hydrochloride (1:1) | C9H16ClN3O2 | 233.7 | | |
| 167 | 1610362-98-5 | APA APA MPO | C12H24ClN5O | 289.81 | | |
| 168 | 1610366-43-2 | Urcosimod | C101H152N14O27 | 1994.37 | | |
| 169 | 1610368-00-7 | tert-butyl N-[(1R,2R)-2-aminocyclobutyl]carbamate | C9H18N2O2 | 186.25 | | |
| 170 | 1610369-16-8 | 2,6-dibromo-4,8-bis(5-dodecylthiophene-2-yl)benzo[1,2-b:4,5-b']dithiophene | C42H56Br2S4 | 848.96 | | |
| 171 | 161037-66-7 | 2-methyl-4-(pyridin-2-yl)phenol | C12H11NO | 185.22 | | |
| 172 | 1610372-97-8 | 3-chloro-N,N-dimethyl-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide | C15H21BClNO3 | 309.6 | | |
| 173 | 1610374-18-9 | 3(2H)-Pyridazinone, 2-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)- | C11H17BN2O3 | 236.08 | | |
| 174 | 1610377-10-0 | 7-Ethyl-6,7-dihydro[1,2,4]triazolo-[4,3-a]pyrazine-3,8(2H,5H)-dione | C7H10N4O2 | 182.18 | | |
| 175 | 1610377-11-1 | 4-Ethyl-2-(1H-pyrrol-1-yl)-1,3-thiazole-5-carboxylic acid | C10H10N2O2S | 222.26 | | |
| 176 | 1610377-12-2 | 2-(4-Methoxyphenyl)-4-oxo-4,5-dihydro-pyrazolo[1,5-a]pyrazine-3-carbaldehyde | C14H11N3O3 | 269.26 | | |
| 177 | 1610377-19-9 | 4-Oxo-2-phenyl-4,5-dihydropyrazolo-[1,5-a]pyrazine-3-carbaldehyde | C13H9N3O2 | 239.23 | | |
| 178 | 1610377-20-2 | N-Methoxy-1-(4-methoxyphenyl)-N-methyl-5-oxopyrrolidine-3-carboxamide | C14H18N2O4 | 278.3 | | |
| 179 | 1610377-21-3 | 4-Chloro-2-(4-methylphenyl)pyrazolo-[1,5-a]pyrazine-3-carbaldehyde | C14H10ClN3O | 271.7 | | |
| 180 | 1610378-55-6 | 2-(4-formyl-3,5-dimethyl-1H-pyrazol-1-yl)ethyl acetate | C10H14N2O3 | 210.23 | | |
| 181 | 1610379-66-2 | 3-Amino-N'-[(2E)-pyrrolidin-2-ylidene]benzohydrazide | C11H14N4O | 218.26 | | |
| 182 | 161038-11-5 | 10-Oxa-2,5,8-triazadodecanoic acid, 5-(2-aminoethyl)-11,11-dimethyl-9-oxo-, 1,1-dimethylethyl ester | C16H34N4O4 | 346.47 | | |
| 183 | 161038-18-2 | 5-FLUORO-8-QUINOLINAMINE | C9H7FN2 | 162.16 | | |
| 184 | 161038-53-5 | 1-methyl-5-(trifluoromethyl)-1H-pyrazol-4-ol | C5H5F3N2O | 166.1 | | |
| 185 | 161038-55-7 | 1H-Pyrazole,3-chloro-1-Methyl-5-(trifluoroMethyl)- | C5H4ClF3N2 | 184.55 | | |
| 186 | 161038-64-8 | 1-Methyl-5-trifluoromethyl-1H-pyrazol-4-ylamine | C5H6F3N3 | 165.12 | | |
| 187 | 1610380-87-4 | (1R)-1-(1-Benzyl-1H-1,2,3-triazol-4-yl)ethan-1-ol >96%ee | C11H13N3O | 203.25 | | |
| 188 | 16104-28-2 | 1,3,5,7-tetrahydroxyadamantane | C10H16O4 | 200.23 | 316-317 °C | |
| 189 | 16104-45-3 | 3,5,6-Methenocyclopentapyrazole, 3,3a,4,5,6,6a-hexahydro- | C7H8N2 | 120.15 | | |
| 190 | 16104-50-0 | 1,3-DICHLOROADAMANTANE | C10H14Cl2 | 205.12 | 130-131 °C | |
| 191 | 16104-96-4 | Ethylene Terephthalate Cyclic Tetramer | C40H32O16 | 768.67 | >300oC | |
| 192 | 16104-97-5 | Ethylene Terephthalate Cyclic Pentamer | C50H40O20 | 960.84 | 256-259oC | |
| 193 | 16104-98-6 | 3,6,9,16,19,22-Hexaoxatricyclo[22.2.2.211,14]triaconta-11,13,24,26,27,29-hexaene-2,10,15,23-tetrone | C24H24O10 | 472.44 | | |
| 194 | 161040-05-7 | N-(But-3-yn-1-yl)-4-methylbenzenesulfonamide | C11H13NO2S | 223.29 | 91-92 °C(Solv: hexane (110-54-3)) | |
| 195 | 161040-21-7 | 2-Propanone, 1-(tetrahydro-2-furanyl)-, (S)- (9CI) | C7H12O2 | 128.17 | | |
| 196 | 161040-25-1 | FENOTEROL DEGRADATION IMPURITY A | C18H21NO4 | 315.36 | >196°C (dec.) | |
| 197 | 1610408-96-2 | 2-Pyridinamine, 5-fluoro-4-(4-fluoro-2-methoxyphenyl)-N-[4-[[[S(R)]-S-methylsulfonimidoyl]methyl]-2-pyridinyl]- | C19H18F2N4O2S | 404.43 | | |
| 198 | 1610408-97-3 | 2-Pyridinamine, 5-fluoro-4-(4-fluoro-2-methoxyphenyl)-N-[4-[[[S(S)]-S-methylsulfonimidoyl]methyl]-2-pyridinyl]- | C19H18F2N4O2S | 404.44 | | |
| 199 | 1610413-96-1 | EC1169 | C78H112N14O28S3 | 1790 | | |
| 200 | 1610413-97-2 | 2-(4-((9S,13S)-9,13-Bis(Tert-Butoxycarbonyl)-18,18-Dimethyl-3,11,16-Trioxo-17-Oxa-2,4,10,12-Tetraazanonadecyl)Phenyl)Acetic Acid | C34H54N4O10 | 678.81336 | | |
| 201 | 1610414-00-0 | EC1167 | | | | |
| 202 | 1610416-51-7 | (2-Chloro-4-cyclopropylphenyl)methanol | C12H17NO | 191.27 | | |
| 203 | 1610416-69-7 | 1-Bromo-2-chloro-4-(methoxymethyl)benzene | C8H8BrClO | 235.51 | | |
| 204 | 1610418-15-9 | 2,2,2-Trifluoro-1-(3-(methoxymethyl)phenyl)ethanone | C10H9F3O2 | 218.17 | | |
| 205 | 1610418-18-2 | tert-butyl (3S,4S)-3-fluoro-4-(hydroxymethyl)piperidine-1-carboxylate | C11H20FNO3 | 233.2798032 | | |
| 206 | 1610418-19-3 | (3S,4R)-tert-Butyl 3-fluoro-4-(hydroxymethyl)piperidine-1-carboxylate | C11H20FNO3 | 233.28 | | |
| 207 | 161042-10-0 | 2-(2',3',5'-triiodobenzoyl)ethyl methacrylate | C13H11I3O4 | 611.94 | 95 °C(Solv: ethyl acetate (141-78-6)) | |
| 208 | 1610420-28-4 | 3-(4-Chlorophenyl)-4,5-dihydro-N''-(1-iminoethyl)-4-phenyl-N-[[4-(trifluoromethyl)phenyl]sulfonyl]-1H-pyrazole-1-carboximidamide | C25H21ClF3N5O2S | 547.98 | | |
| 209 | 1610421-14-1 | Benzo[b]phenanthridine-5,7,12(6H)-trione, 6-(2-propyn-1-yl)- | C20H11NO3 | 313.31 | | |
| 210 | 1610424-35-5 | 4,5-Dicyano-2-ferrocenylimidazole | | | | |
| 211 | 1610426-55-5 | Propanamide, 2,2-dimethyl-N-pyrrolo[2,1-f][1,2,4]triazin-4-yl- | C11H14N4O | 218.26 | | |
| 212 | 1610428-15-3 | Ethyl 5-bromothieno[2,3-c]pyridine-2-carboxylate | C10H8BrNO2S | 286.14 | | |
| 213 | 161043-07-8 | FluazimImpurity2 | C13H5Cl2F3N4O6 | 441.1 | | |
| 214 | 161043-38-5 | 1-(Bromomethyl)bicyclo[1.1.1]pentane | C6H9Br | 161.05 | | |
| 215 | 161043-66-9 | bruceajavanin A | C34H48O7 | 568.75 | | |
| 216 | 161043-67-0 | bruceajavanin B | C33H48O6 | 540.74 | | |
| 217 | 1610431-21-4 | E104 | C21H23N5 | 345.44 | | |
| 218 | 161045-76-7 | (4-Bromo-2-fluorophenyl) 1,1,2,3,3,3-hexafluoropropyl ether | C9H4BrF7O | 341.02 | | |
| 219 | 161045-77-8 | (4-BROMO-2,6-DIFLUOROPHENYL)-1,1,2,3,3,3-HEXAFLUOROPROPYL ETHER | C9H3BrF8O | 359.01 | | |
| 220 | 161045-78-9 | (4-BROMO-2-CHLORO-6-FLUOROPHENYL)-1,1,2,3,3,3-HEXAFLUOROPROPYL ETHER | C9H3BrClF7O | 375.47 | | |
| 221 | 161045-79-0 | 4-Bromo-2-chloro-6-fluorophenol | C6H3BrClFO | 225.44 | | |
| 222 | 1610457-25-4 | 1H-Indole-2,3-dione, 4-(phenylmethoxy)- | C15H11NO3 | 253.25 | | |
| 223 | 1610468-84-2 | Cyclohexene, 4,4-difluoro- | C6H8F2 | 118.12 | | |
| 224 | 1610469-23-2 | 5H,6H,7H,8H-IMIDAZO[1,2-A]PYRIDIN-5-YLMETHANOL | C8H12N2O | 152.19 | | |
| 225 | 1610469-86-7 | tert-Butyl (4-ethynyl-2-fluorobenzyl)carbamate | C14H16FNO2 | 249.29 | | |
| 226 | 1610471-16-3 | 2-Bromo-6-fluoro-4-(trifluoromethyl)phenol | C7H3BrF4O | 259 | | |
| 227 | 1610471-17-4 | Benzene, 1-bromo-3-fluoro-2-(phenylmethoxy)-5-(trifluoromethyl)- | C14H9BrF4O | 349.12 | | |
| 228 | 1610471-69-6 | 4,4',4'',4'''-(pyrene-1,3,6,8-tetrayl)tetraaniline | C40H30N4 | 566.69 | | |
| 229 | 16105-06-9 | 5-oxo-L-proline, cadmium salt | C10H12CdN2O6 | 368.62308 | | |
| 230 | 16105-24-1 | 3-Hydroxy-1-indazolecarboxylic acid ethyl ester | C10H10N2O3 | 206.19 | | |
| 231 | 16105-44-5 | Ethyl 2-(benzo[d]oxazol-2-yl)acetate | C11H11NO3 | 205.21 | 65-66 °C | |
| 232 | 16105-49-0 | 3H-Pyrazol-3-one,5-ethoxy-2,4-dihydro-2-phenyl- | C11H12N2O2 | 204.22518 | | |
| 233 | 16105-69-4 | 2-amino-1-hydroxy-octadecan-3-one | C18H37NO2 | 299.49 | | |
| 234 | 16105-77-4 | FENFLURAMINE HYDROCHLORIDE | C12H17ClF3N | 267.72 | 166 C | |
| 235 | 16105-78-5 | (±)-N-ethyl-alpha-methylphenethylamine hydrochloride | C11H18ClN | 199.72032 | | |
| 236 | 161050-58-4 | METHOXYFENOZIDE | C22H28N2O3 | 368.47 | 204-205° | |
| 237 | 1610501-69-3 | N'-[(2E)-3-(furan-2-yl)prop-2-enoyl]-4-nitrobenzohydrazide | C14H11N3O5 | 301.25 | | |
| 238 | 1610504-84-1 | Benzenepentanamide, 4-hydroxy-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-β-oxo- | C22H24N2O4 | 380.44 | | |
| 239 | 1610516-67-0 | ML318 | C14H8F4N2 | 280.2203328 | | |
| 240 | 1610517-55-9 | Methyl 2-[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]acetate | C15H21BO5 | 292.14 | | |
| 241 | 1610517-97-9 | N,N-[(1-methyl-1H-pyrazol-4-yl)carbonimidoyl]bis-C,C-bis(phenylmethyl) ester(WXC08525) | C21H21N5O4 | 407.42254 | | |
| 242 | 1610518-08-5 | TBS-5 | | | | |
| 243 | 1610520-27-8 | 4-oxo-4,5-dihydrothieno[3,2-c]pyridine-2-carbaldehyde | C8H5NO2S | 179.2 | | |
| 244 | 1610520-28-9 | 7-bromo-4-oxo-4,5-dihydrothieno[3,2-c]pyridine-2-carbaldehyde | C8H4BrNO2S | 258.09 | | |
| 245 | 1610520-29-0 | 7-bromo-5-methyl-4-oxo-4,5-dihydrothieno[3,2-c]pyridine-2-carbaldehyde | C9H6BrNO2S | 272.12 | | |
| 246 | 1610521-10-2 | 4-broMo-2-(cyclopropylMethoxy)pyridine | C9H10BrNO | 228.09 | | |
| 247 | 1610521-45-3 | N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)picolinamide | C18H21BN2O3 | 324.18194 | | |
| 248 | 1610527-49-5 | (2,4-diMethylphenyl)(2-nitrophenyl)sulfane | C14H13NO2S | 259.32352 | | |
| 249 | 161053-46-9 | [1-(2-methoxynaphthalen-1-yl)naphthalen-2-yl]-diphenylphosphane | C33H25OP | 468.524761 | | |
| 250 | 1610530-35-2 | 5-Ethynyl-2'-deoxyuridine-13C2 | | | | |
| 251 | 1610530-40-9 | 5-Ethynyl-2'-deoxyuridine-13C1 | | | | |
| 252 | 1610531-11-7 | 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-2-(phenylmethyl)-1,3-benzenediol | C21H18O3 | 318.37 | | |
| 253 | 1610533-56-6 | 1,3,5-Triazine-2,4,6-triamine, N2-methoxy-N2-methyl-N4-propyl-N6-2-propyn-1-yl- | C11H18N6O | 250.3 | | |
| 254 | 1610535-09-5 | 1,3,5-Triazin-2-aminium, 4-(methoxymethylamino)-N,N,N-trimethyl-6-(propylamino)-, chloride (1:1) | C11H23N6O.Cl | 290.79 | | |
| 255 | 1610535-11-9 | 1,3,5-Triazin-2-aminium, 4-(methoxymethylamino)-N,N,N-trimethyl-6-(propylamino)-, tetrafluoroborate(1-) (1:1) | C11H23N6O.BF4 | 342.14 | | |
| 256 | 1610536-69-0 | MELK-T1(JNJ-47117096) HCl | C21H23ClN4O2 | 398.89 | | |
| 257 | 1610537-15-9 | VT-464 | C18H17F4N3O3 | 399.35 | | |
| 258 | 1610537-23-9 | Benzeneacetamide, α-amino-N-hydroxy-, hydrochloride (1:1), (αS)- | C8H10N2O2.ClH | 202.64 | | |
| 259 | 1610537-25-1 | Benzamide, 4-[[(4-chlorophenyl)sulfonyl]amino]-N-hydroxy- | C13H11ClN2O4S | 326.76 | | |
| 260 | 1610538-11-8 | methyl 4,4,4-trifluoro-2-hydroxybutanoate | C5H7F3O3 | 172.1 | | |
| 261 | 161054-04-2 | 2,1-Benzoxaphosphol-3(1H)-one, 1,1-dicyclohexyl-1,1-dihydro-, stereoisomer (9CI) | C19H27O2P | 318.39 | | |
| 262 | 161054-07-5 | Dicyclohexylphenylphosphine tetrafluoroborate | C18H27BF4P- | 361.1853538 | | |
| 263 | 161054-67-7 | Propanoic acid, 2-hydroxy-3-(methylamino)-, (2S)- | C4H9NO3 | 119.12 | | |
| 264 | 1610543-10-6 | TB-1990 | C10H14O2 | 166.22 | | |
| 265 | 1610543-93-5 | 1H-Pyrazole-4-carboxaldehyde, 3-(difluoromethyl)- | C5H4F2N2O | 146.09 | | |
| 266 | 1610546-44-5 | Pregabalin Impurity 14 | C7H11NO3 | 157.17 | | |
| 267 | 1610549-84-2 | 4-chlorobenzaldehyde 1,2-dihydro[1,2,4]triazino[4,3-a]benzimidazol-3-ylhydrazone | C16H13ClN6 | 324.76762 | | |
| 268 | 161055-35-2 | Oxiranemethanol, 3-[2-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-5-(trimethylsilyl)-4-pentynyl]-, [2R-[2α,3β(R*)]]- (9CI) | C17H34O3Si2 | 342.62 | | |
| 269 | 161055-39-6 | 1-Octen-7-yn-3-ol, 5-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-8-(trimethylsilyl)-, (3S,5R)- | C17H34O2Si2 | 326.62 | | |
| 270 | 161055-41-0 | (5R,7S)-2,2,3,3,9,9,10,10-octamethyl-5-(prop-2-ynyl)-7-vinyl-4,8-dioxa-3,9-disilaundecane | C20H40O2Si2 | 368.7 | | |
| 271 | 161055-47-6 | N1-Acetylsulfamethoxazol | C11H9N3O2S2 | 279.34 | | |
| 272 | 161055-48-7 | Benzenepropanamide, α-(acetylamino)-N-(2-cyano-6-benzothiazolyl)-, (S)- (9CI) | C19H16N4O2S | 364.42 | | |
| 273 | 1610550-64-5 | 2-({2-chloro-5-nitrobenzylidene}amino)-1H-isoindole-1,3(2H)-dione | C15H8ClN3O4 | 329.69 | | |
| 274 | 1610550-83-8 | 3-[4-chloro-3-(trifluoromethyl)anilino]-1-(3,4-dimethoxyphenyl)-2-propen-1-one | C18H15ClF3NO3 | 385.76 | | |
| 275 | 1610552-15-2 | 5-(3-thienylmethylene)-2-thioxo-3-[3-(trifluoromethyl)phenyl]-1,3-thiazolidin-4-one | C15H8F3NOS3 | 371.4203296 | | |
| 276 | 1610559-20-0 | 1610559-20-0 | | | | |
| 277 | 1610559-24-4 | 1610559-24-4 | | | | |
| 278 | 1610561-69-7 | 5-ethoxy-1,2,3-trifluorobenzene | C8H7F3O | 176.14 | | |
| 279 | 1610562-74-7 | BMS-986118 | C25H28ClF3N4O4 | 540.96 | | |
| 280 | 1610563-78-4 | (S)-3-[(4S,5R)-1-[6-[[1-(5-Chloro-2-methoxypyridin-4-yl)-3-methylpiperidin-4-yl]oxy]pyridin-3-yl]-4-methyl-3-(trifluoromethyl)-4,5-dihydro-1H-pyrazole-5-carbonyl]-4-phenyloxazolidin-2-one | C32H32ClF3N6O5 | 673.08 | | |
| 281 | 161057-69-8 | Quinolinium, 2-chloro-4-[(3-methyl-2(3H)-benzothiazolylidene)methyl]-1-phenyl-, iodide (1:1) | C24H18ClIN2S | 528.84 | | |
| 282 | 161057-93-8 | Pirfenidone Impurity 4 | C12H11NO | 185.22 | | |
| 283 | 161058-27-1 | 2-Ethanesulfonyl-benzoic acid | C9H10O4S | 214.24 | | |
| 284 | 161058-83-9 | O6-Cyclohexylmethylguanine | C12H17N5O | 247.3 | 199°C(lit.) | |
| 285 | 1610585-77-7 | 6-Amino-7,9-dihydro-7-(4-phenoxyphenyl)-9-(3-pyrrolidinyl)-8H-purin-8-one | C21H20N6O2 | 388.42 | | |
| 286 | 1610586-62-3 | MELK-T1(JNJ-47117096) | C21H22N4O2 | 362.42 | | |
| 287 | 1610591-93-9 | Thieno[2,3-b]pyridine-2-carboxamide, 3-amino-N-[5-[4-(2,3-dichlorophenyl)-1-piperazinyl]pentyl]-4,6-dimethyl- | C25H31Cl2N5OS | 520.52 | | |
| 288 | 1610596-19-4 | 1H-Indole-1-propanoic acid, 2-[[2-[(9H-fluoren-9-ylmethoxy)carbonyl]-1,2-dimethylhydrazinyl]methyl]-, 2,3,4,5,6-pentafluorophenyl ester | C35H28F5N3O4 | 649.61 | | |
| 289 | 1610597-08-4 | N-[6-(4-cyanobut-1-ynyl)pyridazin-3-yl]-2-[3-(trifluoromethoxy)phenyl]acetamide | C18H13F3N4O2 | 374.3166296 | | |
| 290 | 16106-01-7 | 3,6-Dodecadienoic acid methyl ester | C13H22O2 | 210.31 | | |
| 291 | 16106-03-9 | 7,10-Hexadecadienoic acid methyl ester | C17H30O2 | 266.42 | | |
| 292 | 16106-20-0 | ISOSORBIDE 2-MONONITRATE | C6H9NO6 | 191.14 | | |
| 293 | 16106-28-8 | 9-Octadecenoic acid 2-phenyl-1,3-dioxan-5-yl ester | C28H44O4 | 444.65 | | |
| 294 | 16106-38-0 | 4-Aminobenzoyl chloride | C7H6ClNO | 155.58 | | |
| 295 | 16106-40-4 | Anthracene-2-sulfonic acid sodium salt | | | | |
| 296 | 16106-44-8 | potassium toluene-4-sulphonate | C7H8O3S.K | 210.292 | | |
| 297 | 16106-59-5 | 4,5-DIMETHYL-1-HEXENE | C8H16 | 112.21 | -103.01°C (estimate) | |
| 298 | 16106-81-3 | 1,11-Dichloro-1,1,3,3,5,5,7,7,9,9,11,11-dodecamethylhexasiloxane | C12H36Cl2O5Si6 | 499.83 | -80 °C | |
| 299 | 16106-95-9 | 2Z,6Z-Farnesol | C15H26O | 222.37 | | |
| 300 | 1610605-20-3 | Boc-(2S,4S)-perfluoro-tert-butyl-4-hydroxyproline | C14H16F9NO5 | 449.27 | | |
| 301 | 1610605-66-7 | 1610605-66-7 | | | | |
| 302 | 1610605-73-6 | 1610605-73-6 | | | | |
| 303 | 1610606-83-1 | Cefmenoxime Impurity 23 | C14H15N5O6S2 | 413.43 | | |
| 304 | 1610606-84-2 | 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2E)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-3-(hydroxymethyl)-8-oxo-, (6R,7R)- | C14H15N5O6S2 | 413.43 | | |
| 305 | 1610606-85-3 | Cefmenoxime Impurity 25 | C16H17N9O6S3 | 527.56 | | |
| 306 | 1610606-86-4 | Cefmenoxime Impurity 26 | C16H17N9O5S3 | 511.56 | | |
| 307 | 1610606-91-1 | 1-TERT-BUTYL 3-METHYL 2,3-DIHYDRO-1H-PYRROLE-1,3-DICARBOXYLATE | C11H17NO4 | 227.26 | | |
| 308 | 1610606-95-5 | (1R,4R,5R)-2-(tert-butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-4-carboxylic acid | C11H17NO4 | 227.26 | | |
| 309 | 1610606-97-7 | (1S,4R,5S)-2-(tert-butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-4-carboxylic acid | C11H17NO4 | 227.26 | | |
| 310 | 1610610-48-4 | KDU731 | C22H16N6O2 | 396.40 | | |
| 311 | 1610611-84-1 | methyl 3-bromopyrazolo[1,5-a]pyridine-5-carboxylate | C9H7BrN2O2 | 255.07 | | |
| 312 | 1610612-05-9 | methyl3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[1,5-a]pyridine-5-carboxylate(WXC07566) | C15H19BN2O4 | 302.13 | | |
| 313 | 1610612-94-6 | N,5-Dimethylpyridin-3-amine | C7H10N2 | 122.17 | | |
| 314 | 1610613-76-7 | 6-BroMo-4-Methyl-1-hexanol | C7H15BrO | 195.1 | | |
| 315 | 1610618-91-1 | β-D-Glucopyranoside, 2-(3,4-dihydroxyphenyl)ethyl O-D-apio-β-D-furanosyl-(1→6)-O-[6-deoxy-α-L-mannopyranosyl-(1→3)]- | C25H38O16 | 594.56 | | |
| 316 | 161062-65-3 | tetramethyl 8H-dithieno[2,3-a:3,4-c]quinolizine-8,9,10,11-tetracarboxylate | C21H17NO8S2 | 475.49158 | | |
| 317 | 1610620-88-6 | Propanoic acid, 2-hydroxy-3-(2-methylphenoxy)-, (2S)- | C10H12O4 | 196.2 | | |
| 318 | 1610620-90-0 | Propanoic acid, 3-(2-chlorophenoxy)-2-hydroxy-, (2S)- | C9H9ClO4 | 216.62 | | |
| 319 | 161063-05-4 | oxygen(-2) anion | Al2Ca2O5 | 16 | | |
| 320 | 161063-22-5 | 1-(4-Bromophenyl)-2-(4-methoxyphenyl)-1H-pyrrole | C17H14BrNO | 328.2 | | |
| 321 | 161063-23-6 | 1-(4-Bromophenyl)-2-phenyl-1H-pyrrole | C16H12BrN | 298.18 | | |
| 322 | 161063-30-5 | Cyclobutanecarbonyl isothiocyanate (9CI) | C6H7NOS | 141.19 | | |
| 323 | 161063-31-6 | Cyclobutanecarboxamide, N-(aminothioxomethyl)- (9CI) | C6H10N2OS | 158.22 | | |
| 324 | 161064-82-0 | Pentanoic acid, 3-amino-5-hydroxy-4,4-dimethyl- | C7H15NO3 | 161.2 | | |
| 325 | 161064-85-3 | 3,7-Dioxa-1-azabicyclo[4.1.0]heptane,5,5-dimethyl-2-(1-methylethyl)-,cis-(9CI) | C9H17NO2 | 171.24 | | |
| 326 | 161066-04-2 | 2-Amino-9-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-8-(4-(hydroxymethyl)phenyl)-1H-purin-6(9H)-one | C17H19N5O5 | 373.36 | | |
| 327 | 1610665-07-0 | 2,5-dioxopyrrolidin-1-yl 2-(((butylthio)carbonothioyl)thio)propanoate | | | | |
| 328 | 1610666-09-5 | DABIGATRAN ETEXILATE | C34H41N7O5 | 627.75 | | |
| 329 | 1610667-12-3 | (2-Fluoro-pyridin-3-yl)-methyl-amine | C6H7FN2 | 126.13 | | |
| 330 | 1610667-14-5 | 6-Fluoro-N-methylpyridin-3-amine | C6H7FN2 | 126.13 | | |
| 331 | 1610667-17-8 | 5-Chloro-N-methylpyrazin-2-amine | C5H6ClN3 | 143.57 | | |
| 332 | 1610676-27-1 | CFI-401980 | C28H30N6O3 | 498.58 | | |
| 333 | 1610677-36-5 | N-cyclopropyl-4-(7-((cyclopropylmethyl)amino)-5-(((1S,2R)-2-hydroxycyclohexyl)amino)pyrazolo[1,5-a]pyrimidin-3-yl)-2-methylbenzamide hydrochloride | | | | |
| 334 | 1610677-37-6 | CFI-402257 HCl | C28H31ClN6O3 | 535.05 | | |
| 335 | 1610678-59-5 | luvixasertib isomer | C28H30N6O3 | 498.58 | | |
| 336 | 161068-48-0 | 3-Cyclohexene-1,2-diacetic acid, 6-(β-D-glucopyranosyloxy)-1-hydroxy-3-(methoxycarbonyl)- (9CI) | C18H26O13 | 450.39 | | |
| 337 | 161068-53-7 | Epimedokoreanin B | C25H26O6 | 422.47034 | | |
| 338 | 161068-59-3 | Aconitane-6,7,8-triol, 4-[[[2-(2,5-dioxo-1-pyrrolidinyl)benzoyl]oxy]methyl]-20-ethyl-1,14,16-trimethoxy-, 8-acetate, (1α,6β,14α,16β)- (9CI) | C37H48N2O11 | 696.78 | | |
| 339 | 161068-60-6 | Benzo[b]pyrido[4,3,2-de]quino[2,3,4-gh][1,10]phenanthroline | C24H12N4 | 356.38 | | |
| 340 | 161068-62-8 | 6-Indolizinemethanol, 1,2,3,5,6,7-hexahydro-6-methyl-α-(1-methylethylidene)-, (+)- | C13H21NO | 207.31 | | |
| 341 | 161068-67-3 | Furo[2,3-b]quinolin-7(8H)-one,5-hydroxy-4,8-dimethoxy-8-(3-methyl-2-buten-1-yl)-, (-)- | C18H19NO5 | 329.34716 | | |
| 342 | 161068-68-4 | Murranimbine | C36H34N2O2 | 526.68 | | |
| 343 | 161068-69-5 | 2-Oxazolemethanamine, 5-(1H-indol-3-yl)-N,N-dimethyl-α-(phenylmethyl)-, (αS)- | C21H21N3O | 331.41 | | |
| 344 | 161068-70-8 | Benzenepropanamide, α-(dimethylamino)-N-[2-(1H-indol-3-yl)-2-oxoethyl]-, (αS)- | C21H23N3O2 | 349.43 | | |
| 345 | 161068-73-1 | Aconitane-1,14-diol,3,4-epoxy-20-ethyl-16-methoxy-8,9-[methylenebis(oxy)]-, (1a,3b,14a,16b)- (9CI) | C22H31NO6 | 405.49 | | |
| 346 | 161068-74-2 | Aconitane-4,8-diol,20-ethyl-1,6,14,16-tetramethoxy-, 4-acetate, (1a,6a,14a,16b)- (9CI) | C26H41NO7 | 479.61 | | |
| 347 | 161068-75-3 | Aconitane-1,8-diol, 3,4-epoxy-20-ethyl-6,14,16-trimethoxy-, (1α,3β,6α,14α,16β)- (9CI) | C23H35NO6 | 421.53 | | |
| 348 | 1610688-72-6 | METHYL 3-(2-CHLOROPHENYL)-5-[2-(DIMETHYLAMINO)VINYL]-4-ISOXAZOLECARBOXYLATE | C15H15ClN2O3 | 306.74 | | |
| 349 | 1610688-76-0 | METHYL 3-(2,6-DICHLOROPHENYL)-5-[2-(DIMETHYLAMINO)VINYL]-4-ISOXAZOLECARBOXYLATE | C15H14Cl2N2O3 | 341.19 | | |
| 350 | 1610688-77-1 | METHYL 5-[2-(DIMETHYLAMINO)VINYL]-3-PHENYL-4-ISOXAZOLECARBOXYLATE | C15H16N2O3 | 272.3 | | |
| 351 | 1610688-92-0 | 5-[2-(DIMETHYLAMINO)VINYL]-3-PHENYL-4-ISOXAZOLECARBONITRILE | C14H13N3O | 239.27 | | |
| 352 | 1610689-08-1 | 4-(3-(trifluoromethyl)-3H-diazirin-3-yl)aniline | C8H6F3N3 | 201.15 | | |
| 353 | 161069-06-3 | Dimethyltetradecylnaphthylmethylammoniumchloride | C27H44ClN | 418.09796 | | |
| 354 | 1610690-08-8 | (S)-1-Chloro-3-((3-fluoro-4-Morpholinophenyl)aMino)propan-2-ol | C13H18ClFN2O2 | 288.75 | | |
| 355 | 1610690-72-6 | 3-[(4-Ethenylphenyl)methoxy]benzoic acid | | | | |
| 356 | 1610690-74-8 | 4-[(4-Ethenylphenyl)methoxy]-3-methoxybenzoic acid | | | | |
| 357 | 1610690-76-0 | 4-[(4-Ethenylphenyl)methoxy]-3-methylbenzoic acid | | | | |
| 358 | 1610697-74-9 | tert-Butyl (R)-3-(4-amino-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)pyrrolidine-1-carboxylate | | | | |
| 359 | 1610697-81-8 | tert-butyl (R)-3-(4-amino-6-bromo-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)pyrrolidine-1-carboxylate | | | | |
| 360 | 1610698-55-9 | 4-((4-Methylpyridin-2-yl)carbamoyl)phenylboronic acid | C13H13BN2O3 | 256.06 | | |
| 361 | 16107-82-7 | Quinazoline, 4-(4-methylphenyl)-2-phenyl- | C21H16N2 | 296.37 | | |
| 362 | 16107-88-3 | 2-(4-methylphenyl)-4,6-diphenyl-s-triazine | C22H17N3 | 323.39 | | |
| 363 | 161070-01-5 | Propofol Impurity 7 | C13H18O3 | 222.28 | | |
| 364 | 1610701-22-8 | [1,1':4',1'':4'',1'''-Quaterphenyl]-3,3''',5,5'''-tetracarboxylic acid, 2',3'',5'',6'-tetramethyl- | C32H26O8 | 538.54 | | |
| 365 | 1610703-09-7 | N-cyclopropene-L-Lysine | C12H20N2O4 | 256.3 | | |
| 366 | 1610703-10-0 | tert-butyl (2-(5-azidopentanamido)ethyl)carbamate | C12H23N5O3 | 285.35 | | |
| 367 | 1610703-69-9 | 6-chloro-9-ethyl-8-iodo-9H-purine | C7H6ClIN4 | 308.51 | | |
| 368 | 1610704-18-1 | 1-Pyrrolidinecarboxylic acid, 3-amino-2-methyl-, 1,1-dimethylethyl ester, (2R,3S)- | C10H20N2O2 | 200.28 | | |
| 369 | 1610704-23-8 | 2-(tert-butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-6-carboxylic acid | C11H17NO4 | 227.25698 | | |
| 370 | 1610705-51-5 | Methyl 5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)pyriMidine-2-carboxylate | C12H17BN2O4 | 264.08538 | | |
| 371 | 1610707-94-2 | (Z)-3-(dibenzylamino)cyclohexan-1-oneoxime | C20H24N2O | 308.43 | | |
| 372 | 1610714-49-2 | tert-Butyl 4-(Benzyloxy)-3,3-difluoropyrrolidine-1 -carboxylate... | C16H21F2NO3 | 313.34 | | |
| 373 | 1610729-47-9 | 2-Pyridineacetic acid, 5-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-, methyl ester | C14H23NO3Si | 281.42 | | |
| 374 | 1610729-62-8 | methyl 2-(3-nitropyridin-2-yl)acetate | C8H8N2O4 | 196.16 | | |
| 375 | 1610731-08-2 | Carbonic acid, 4-nitrophenyl 3-(2-pyridinyldithio)propyl ester | C15H14N2O5S2 | 366.41 | | |
| 376 | 1610732-22-3 | XBZSBBLNHFMTEB-WDSKDSINSA-N | C8H12O4 | 172.18 | | |
| 377 | 1610733-46-4 | 3-Nitro-4-(morpholine-4-yl) phenylboronic acid | C10H13BN2O5 | 252.03162 | | |
| 378 | 1610733-89-5 | (6-(piperidin-1-yl)-5-(trifluoromethyl)pyridin-3-yl)boronic acid | C11H14BF3N2O2 | 274.05 | | |
| 379 | 1610734-04-7 | 4-Bromo-5-methyl-2-(trifluoromethyl)phenol | | | | |
| 380 | 161074-57-3 | Fatty acids, C16-18 and C18-hydroxy, polymers with adipic acid, isostearic acid, pentaerythritol and stearic acid | | | | |
| 381 | 161074-67-5 | Glutens, hydrolyzates, reaction products with lauroyl chloride, sodium salts | | | | 278g/L at 25℃ |
| 382 | 161074-79-9 | Alcohols, C12-13, branched and linear, ethoxylated, sulfates, sodium salts | | | | |
| 383 | 161074-85-7 | D-Glucopyranose, oligomers, decyl glycosides | | | | |
| 384 | 161074-87-9 | D-Glucopyranose, oligomeric, lauryl glycosides | | | | |
| 385 | 161074-89-1 | D-Glucopyranose, oligomers, cetyl glycosides | | | | |
| 386 | 161074-90-4 | D-Glucopyranose, oligomeric, stearyl glycosides | | | | |
| 387 | 161074-96-0 | D-Glucopyranose, oligomers, octyl glycosides | | | | |
| 388 | 161074-97-1 | D-Glucopyranose, oligomeric, C8-10-alkyl glycosides | | | | |
| 389 | 161075-00-9 | Hexafluoropropene, oxidized, oligomers, reduced, fluorinated | C3F6 | 150.0225192 | | 470μg/L at 20℃ |
| 390 | 161075-02-1 | POLYPERFLUOROETHOXYMETHOXY DIFLUOROMETHYL ETHER | | | | |
| 391 | 161075-03-2 | Tetrafluoroethylene, oxidized, oligomers, reduced, methyl esters, hydrolyzed | C2F4 | 100.0150128 | | |
| 392 | 161075-12-3 | Ethene, tetrafluoro-, oxidized, polymd., reduced, Me esters | | | | |
| 393 | 161075-14-5 | 1-Propene, 1,1,2,3,3,3-Hexafluoro-, oxidized, polymd., reduced, hydrolized, mittlere Molmasse 3000 g/mol | | | | |
| 394 | 161075-20-3 | Fatty acids, (C=18)-unsatd., dimers polymer with formaldehyde,1,2,3-propanetriol, 2,2-bis(hydroxymethyl)-1,3-propanediol, rosin and 4-(1,1,3,3-tetramethylbutyl)phenol | | | | |
| 395 | 161075-29-2 | Formaldehydepolymer with 6-phenyl | | | | |
| 396 | 161075-48-5 | .beta.-Alanine, N-(2-aminoethyl)-, monosodium salt, polymer with 2,2-dimethyl-1,3-propanediol, hexanedioic acid, 1,6-hexanediol, 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane, 1,1-methylenebis4-isocyanatocyclohexane and 1,5-pentanediol | C54H101N6NaO16 | 1113.42 | | |
| 397 | 1610758-16-1 | ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate 4-methylbenzenesulfonate | C33H35N7O6S | 657.75 | | |
| 398 | 1610758-17-2 | Dabigatran Methyl Ester Impurity | C28H31N7O3 | 513.6 | | |
| 399 | 1610758-19-4 | Dabigatran Etexilate iMpurity 1 | C35H43N7O5 | 641.77 | >124°C (dec.) | |
| 400 | 1610758-20-7 | Dabigatran etexilate Impurity R | C34H41N7O5 | 627.75 | | |
| 401 | 1610758-21-8 | Dabigatran Etexilate iMpurity 4 | C35H43N7O5 | 641.77 | | |
| 402 | 1610758-22-9 | Dabigatran iMpurity D | C34H41N7O5 | 627.75 | | |
| 403 | 1610759-21-1 | N-cyclopropyl-4-(7-((cyclopropylmethyl)amino)-5-(((1S,2R)-2-hydroxycyclohex-yl)amino)pyrazolo[1,5-a]pyrimidin-3-yl)-2-methylbenzamide | C27H34N6O2 | 474.6 | | |
| 404 | 1610759-22-2 | CFI-402257 | C28H30N6O3 | 498.58 | | |
| 405 | 1610761-46-0 | Plozalizumab | | | | |
| 406 | 1610765-80-4 | 2,8-di(pyridin-4-yl)dibenzo[b,d]thiophene | C22H14N2S | 338.42 | | |
| 407 | 1610767-01-5 | tert-butyl (S)-(1-(3-aminophenyl)ethyl)carbamate | C13H20N2O2 | 236.31 | | |
| 408 | 1610769-13-5 | [4-[[(2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-5-(carbamoylamino)pentanoyl]amino]phenyl]methyl N-[2-(pyridin-2-yldisulfanyl)ethyl]carbamate | C26H37N7O5S2 | 591.75 | | |
| 409 | 1610772-20-7 | 6-(p-tolyl)-4-vinylthieno[2,3-d]pyrimidine | | | | |
| 410 | 1610772-26-3 | Thieno[2,3-d]pyrimidine, 4-chloro-6-(4-methylphenyl)- | C13H9ClN2S | 260.74 | | |
| 411 | 1610772-78-5 | 1-oxo-1-phenylpropan-2-yl (E)-cinnamate | C18H16O3 | 280.32 | | |
| 412 | 1610773-83-5 | 4'-Methyl-N,N-bis(1-methylethyl)[1,1'-biphenyl]-3-carboxamide | C20H25NO | 295.43 | | |
| 413 | 1610773-85-7 | 4'-Fluoro-N,N-bis(1-methylethyl)[1,1'-biphenyl]-3-carboxamide | C19H22FNO | 299.39 | | |
| 414 | 1610777-30-4 | N-(3-azidopropyl)-3-(pyridin-2-yldisulfanyl)propanamide | C10H13N5OS2 | 283.37 | | |
| 415 | 1610778-74-9 | Guanosine 5'-(tetrahydrogen triphosphate), 2'-O-(phenylmethyl)- | C17H22N5O14P3 | 613.3 | | |
| 416 | 1610778-75-0 | 3'-O-Bn-GTP | | | | |
| 417 | 1610785-35-7 | (2R,2'R,3R,3'R)-BIBOP | C22H28O2P2 | 386.4 | | |
| 418 | 1610793-69-5 | 1610793-69-5 | | | | |
| 419 | 1610794-70-1 | MT-1207 | C21H24N6S.ClH | 428.98 | | |
| 420 | 1610796-02-5 | Azido-PEG12-NHS ester | C31H57N4O16+ | 741.80148 | | |
| 421 | 1610799-82-0 | trifluoroacetic acid | C6H10F3NO4S | 249.2 | | |
| 422 | 16108-03-5 | N-FORMYL-DL-TRYPTOPHAN | C12H12N2O3 | 232.24 | 167°C | |
| 423 | 16108-10-4 | 2,3,4,9-Tetrahydro-1-methyl-1H-pyrido[3,4-b]indole-3-carboxylic acid methyl ester | C14H16N2O2 | 244.29 | | |
| 424 | 16108-39-7 | 2(3H)-Furanone,4-(1,3-benzodioxol-5-ylcarbonyl)dihydro- | C12H10O5 | 234.2048 | | |
| 425 | 16108-48-8 | Ethyl 2-hydroxy-4,6-diMethylnicotinate | C10H13NO3 | 195.21512 | 136 °C | |
| 426 | 16108-50-2 | 2'-hydroxy-4',6'-dimethylacetophenone | C10H12O2 | 164.2 | 62°C | |
| 427 | 16108-51-3 | 2 6-DIMETHYLCHROMONE | C11H10O2 | 174.2 | 103-104 °C(Solv: ligroine (8032-32-4)) | |
| 428 | 16108-98-8 | N,N'-(methylenedi-4,1-phenylene)bis(stearamide) | C49H82N2O2 | 731.19 | | |
| 429 | 1610800-25-3 | Diacylglycerol acyltransferase inhibitor-1 | C21H23N5O2 | 377.44 | | |
| 430 | 1610800-91-3 | Methyl 4-(2-oxo-1,2,5,6,7,8-hexahydroquinoline-3-carboxamido)but-2-enoate | C15H18N2O4 | 290.31 | | |
| 431 | 1610802-47-5 | CERC611) | C19H18N4O3S | 382.44 | | |
| 432 | 1610802-53-3 | Pyridine, 2-fluoro-5-[2-[(tetrahydro-2H-pyran-2-yl)oxy]ethoxy]- | C12H16FNO3 | 241.26 | | |
| 433 | 161082-75-3 | 1,2-Dicyano-4-Dodecyloxybenzene | C20H28N2O | 312.45 | 62℃ | |
| 434 | 1610827-31-0 | 6-butyl-1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl trifluoromethanesulfonate | C17H14F3NO5S | 401.36 | | |
| 435 | 1610830-81-3 | Dithio-Desethyl Carbodenafil | C22H28N6OS2 | 456.63 | | |
| 436 | 1610833-03-8 | Burosumab | | | | |
| 437 | 1610838-97-5 | Sarolaner Impurity 5 | C23H18Cl2F4N2O5S | 581.37 | | |
| 438 | 161084-29-3 | 2-Butanone, 4,4,4-trifluoro-3-hydroxy- (9CI) | C4H5F3O2 | 142.08 | | |
| 439 | 161084-30-6 | 2-Butanone, 1,1,1-trifluoro-3-hydroxy- (9CI) | C4H5F3O2 | 142.08 | | |
| 440 | 1610846-62-2 | N-(2,6-dimethylphenyl)-N-(2-pyridinylmethylene)amine | C14H14N2 | 210.27436 | | |
| 441 | 161085-48-9 | D-Idonic acid, 3,6-anhydro-, gamma-lactone (9CI) | C6H8O5 | 160.12 | | |
| 442 | 1610851-14-3 | Ketoconazole Impurity 18 | C21H20Cl2N2O5S | 483.36 | | |
| 443 | 1610851-15-4 | Ketoconazole Impurity 6 | C21H20Cl2N2O5S | 483.36 | | |
| 444 | 1610858-95-1 | tetramethyl 4',4'',4''',4''''-(ethene-1,1,2,2-tetrayl)tetrabiphenyl-4-carboxylate | C58H44O8 | 868.96516 | | |
| 445 | 1610858-96-2 | 4',4'',4''',4''''-(ethene-1,1,2,2-tetrayl)tetrabiphenyl-4-carboxylic acid | C54H36O8 | 812.85884 | | |
| 446 | 161086-37-9 | N-[(Phenylmethoxy)carbonyl]glycylglycyl-2-amino-2-deoxy-a-D-manno-2-heptulofuranosonic acid methyl ester | C20H27N3O11 | 485.45 | | |
| 447 | 161087-48-5 | 3-Methyl-2-chloro-3H-imidazo[4,5-f]quinoline | C11H8ClN3 | 217.65 | | |
| 448 | 1610877-14-9 | 3-Benzyl-1-methyl-1H-benzo[d]imidazol-3-ium hexafluorophosphate(V) | C15H15N2.F6P | 368.26 | | |
| 449 | 1610877-91-2 | Glycine, N-[2-[[2-[6-[[[2-[[2-[bis(carboxymethyl)amino]ethyl]dithio]ethoxy]carbonyl]amino]-1,3-dioxo-1H-benz[de]isoquinolin-2(3H)-yl]ethyl]dodecylamino]ethyl]-N-(carboxymethyl)- | C41H59N5O12S2 | | | |
| 450 | 1610877-92-3 | Glycine, N-[2-[[2-(6-amino-1,3-dioxo-1H-benz[de]isoquinolin-2(3H)-yl)ethyl]dodecylamino]ethyl]-N-(carboxymethyl)- | C32H46N4O6 | | | |
| 451 | 1610877-95-6 | Glycine, N-[2-[(2-aminoethyl)dodecylamino]ethyl]-N-[2-(1,1-dimethylethoxy)-2-oxoethyl]-, 1,1-dimethylethyl ester | C28H57N3O4 | | | |
| 452 | 1610877-99-0 | Glycine, N-[2-(1,1-dimethylethoxy)-2-oxoethyl]-N-[2-[(2-hydroxyethyl)dithio]ethyl]-, 1,1-dimethylethyl ester | C16H31NO5S2 | 381.55 | | |
| 453 | 1610878-54-0 | Telomerase inhibitor 2 | C34H39N3O9 | 633.69 | | |
| 454 | 1610878-71-1 | AEF0117 | C29H40O3 | 436.63 | | |
| 455 | 161088-90-0 | Titanium boride (TiB2) | | 61.752 | | |
| 456 | 1610881-44-1 | 4-Cyclooctene-1-carboxylic acid | C9H14O2 | 154.21 | | |
| 457 | 1610881-60-1 | Nintedanib Impurity E (Intedanib Impurity E) | C29H31N5O2 | 481.6 | | |
| 458 | 1610882-30-8 | TCS-OX2-29 HCl | C23H32ClN3O3 | 433.971 | | |
| 459 | 1610886-04-8 | MNKI-8e | C17H18N4O3S | 358.41 | | |
| 460 | 161089-63-0 | 2-chloro-2-propylpentanoic acid | C8H16ClNaO2 | 202.65 | | |
| 461 | 161089-84-5 | 5-methyl-2-propyl-hexanoic acid | C10H20O2 | 172.26 | | |
| 462 | 161089-94-7 | 2-(cyclohexylmethyl)pentanoic acid | C12H22O2 | 198.30188 | | |
| 463 | 1610890-54-4 | 1610890-54-4 | | | | |
| 464 | 1610894-92-2 | 1H-Benzimidazole, 2-(4-bromophenyl)-1-(4-nitrophenyl)- | C19H12BrN3O2 | 394.22 | | |
| 465 | 16109-37-8 | Silane,2,3-dimethyl-2-butene-1,4-diyl)bis[trimethyl-E- | C12H28Si2 | 228.52 | | |
| 466 | 16109-47-0 | Benzenepropanamide, b-imino-N-2-pyridinyl- | C14H13N3O | 239.27252 | | |
| 467 | 16109-82-3 | iodobis(triphenylphosphino)copper | C36H33CuIP2 | 718.06 | | |
| 468 | 16109-97-0 | hydrogen [4-[4-(diethylamino)-alpha-(3,6-disulphonato-1-naphthyl)benzylidene]cyclohexa-2,5-dien-1-ylidene]diethylammonium | C31H34N2O6S2 | | | |
| 469 | 161090-79-5 | Bis(2-cyanoethyl)-1-(N-tert-butyloxycarbonyl)-D-erythro-D-sphingosine-1-phosphate | C29H52N3O7P | 585.71 | | |
| 470 | 161091-03-8 | Boronic acid, (3,3-diethoxy-1-propenyl)-, diethyl ester, (E)- (9CI) | C11H23BO4 | 230.11 | | |
| 471 | 161091-04-9 | (2E)-1-propyenyl-3-boronic acid | C3H5BO3 | 99.88 | 128-131 °C | |
| 472 | 161091-05-0 | 1,3,2-Dioxaborolane, 4,4,5,5-tetramethyl-2-[2-(4,4,5,5-tetramethyl-1,3-dioxolan-2-yl)ethenyl]-, (E)- (9CI) | C15H27BO4 | 282.18 | | |
| 473 | 161091-42-5 | Benzene, 1,3-dimethyl-5-nitro-2-(phenylmethoxy)- | C15H15NO3 | 257.28 | 68-69 °C | |
| 474 | 161091-49-2 | 2-Amino-3-Bromo-5,6-Dimethylpyridine | C7H9BrN2 | 201.06 | 114-116 C | |
| 475 | 161091-50-5 | 2,3-Pyridinediamine,N3,5,6-trimethyl- | C8H13N3 | 151.21 | 86-89°C | |
| 476 | 161091-52-7 | 2-Pyridinamine,3-bromo-N,5,6-trimethyl- | C8H11BrN2 | 215.09 | | |
| 477 | 161091-53-8 | 2,3-Pyridinediamine,N2,5,6-trimethyl- | C8H13N3 | 151.21 | | |
| 478 | 161091-55-0 | 2-AMINO-1,5,6-TRIMETHYLIMIDAZO(4,5-B)PYRIDINE | C9H12N4 | 176.22 | 294-296°C | |
| 479 | 1610919-47-5 | 1610919-47-5 | | | | |
| 480 | 1610919-91-9 | (S)-Azetidine-2-carboxylic acid compound with 2,2,2-trifluoroacetic acid | C6H8F3NO4 | 215.13 | | |
| 481 | 1610919-99-7 | 5H,6H,7H-cyclopenta[b]pyridine-7-carboxylic acid hydrochloride | C9H10ClNO2 | 199.63 | | |
| 482 | 1610931-22-0 | TCO* - NHS carbonate / EQUATORIAL isomer | C13H17NO5 | 267.28 | | |
| 483 | 161094-94-6 | 4-Iodo-1,1,1,2-tetrafluoro-2-(trifluoromethyl)octane | C9H12F7I | 380.08 | | |
| 484 | 1610943-06-0 | Emicizumab | | | | |
| 485 | 161095-11-0 | Neuroprotective agent 4 | C14H17NO2 | 231.29 | | |
| 486 | 161095-35-8 | Benzaldehyde, 3,4-dihydroxy-5-(3-methyl-2-butenyl)- (9CI) | C12H14O3 | 206.24 | | |
| 487 | 161095-84-7 | 1H-Imidazole,1-methyl-4-(1-methyl-1-propenyl)-,(E)-(9CI) | C8H12N2 | 136.19 | | |
| 488 | 1610950-41-8 | 1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid, 10-[2-[[[4-(6-methyl-1,2,4,5-tetrazin-3-yl)phenyl]methyl]amino]-2-oxoethyl]- | C26H37N9O7 | 587.63 | | |
| 489 | 1610950-79-2 | Boronic acid, B-[4-([1,1'-biphenyl]-2-yl[1,1'-biphenyl]-4-ylamino)phenyl]- | C30H24BNO2 | 441.33 | | |
| 490 | 1610954-85-2 | 1610954-85-2 | C14H12BrCl | 295.6 | | |
| 491 | 1610954-86-3 | (3-(4-chlorobenzyl)-4-methylphenyl)((3aS,5R,6S,6aS)-6-hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)methanone | C22H23ClO5 | 402.87 | | |
| 492 | 1610954-87-4 | 1610954-87-4 | C22H25ClO5 | 404.89 | | |
| 493 | 1610954-88-5 | 1610954-88-5 | C27H29ClO9 | 532.97 | | |
| 494 | 1610954-90-9 | (2S,3S,4R,5S,6R)-2-(3-(4-chlorobenzyl)-4-methylphenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triyl triacetate | C26H29ClO7S | 521.02 | | |
| 495 | 1610954-92-1 | 1610954-92-1 | C31H38O9S | 586.7 | | |
| 496 | 1610954-93-2 | 4-(4-(2-methyl-5-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2H-pyran-2-yl)benzyl)phenyl)butanoic acid | C24H30O6S | 446.56 | | |
| 497 | 1610954-97-6 | LX-2761 | C32H47N3O6S | 601.8 | | |
| 498 | 161096-44-2 | Ethanone, 1-(1,3-cyclohexadien-1-yl)-2,2,2-trifluoro- (9CI) | C8H7F3O | 176.14 | | |
| 499 | 161096-82-8 | Oxaloacetic Acid-13C4 | C4H4O5 | 136.10756 | | |
| 500 | 161096-83-9 | α-Ketoglutaric Acid-13C5 | 13C5H6O5 | | | |
| 501 | 1610961-21-1 | Caroverine Impurity 28 | | | | |
| 502 | 1610961-23-3 | Caroverine Impurity 46 | | | | |
| 503 | 1610961-25-5 | Caroverine Impurity 79 | | | | |
| 504 | 1610961-35-7 | Caroverine Impurity 81 | | | | |
| 505 | 1610964-63-0 | 4,6-Pyrimidinediamine, 5-fluoro-2-(5-fluoro-2-methyl-1H-benzimidazol-1-yl)-N4-[4-(trifluoromethyl)phenyl]- | C19H13F5N6 | 420.34 | | |
| 506 | 1610964-64-1 | 5-fluoro-2-(6-fluoro-2-methyl-1H-benzimidazol-1-yl)-N-[4-(trifluoromethyl)phenyl]pyrimidine-4,6-diamine | C19H13F5N6 | 420.34 | | |
| 507 | 1610966-50-1 | Di-tert-butyl (2，6-dichloropyrimidin-4-yl)imidodicarbonate | C14H19Cl2N3O4 | 364.22 | | |
| 508 | 1610966-63-6 | 1-(4,6-dichloro-5-fluoropyrimidin-2-yl)-6-fluoro-2-methyl-1H-benzo[d]imidazole | C12H6Cl2F2N4 | 315.11 | | |
| 509 | 161097-76-3 | 6-BROMOHEXYLTRIETHYLAMMONIUM BROMIDE | C12H27Br2N | 345.16 | | |
| 510 | 161097-77-4 | CIMICIFUGOSIDE H-2 | C35H54O10 | 634.8 | | |
| 511 | 1610970-44-9 | 3-cyclopropylprop-2-yn-1-amine hydrochloride | C6H10ClN | 131.6 | | |
| 512 | 1610974-55-4 | PRN371 | C20H21N5O2 | 363.41 | | |
| 513 | 161098-22-2 | Boron, [(7R)?-?7-?[[12-?[5-?[(3,?5-?dimethyl-?2H-?pyrrol-?2-?ylidene-?κN)?methyl]?-?1H-?pyrrol-?2-?yl-?κN]?-?1-?oxododecyl]?oxy]?-?4-?hydroxy-?N,?N,?N-?trimethyl-?10-?oxo-?3,?5,?9-?trioxa-?4-?phosphapentacosan-?1-?aminium 4-?oxidato(2-?)?]?difluoro-?, (T-?4)? | | | | |
| 514 | 1610980-30-7 | (1,3-dichloropropyl)benzene | C9H10Cl2 | 189.08 | | |
| 515 | 161099-35-0 | 13,30-Cyclodammar-24-en-26-oic acid, 3-(acetyloxy)-7-hydroxy-, (3α,7α,17α,20S,24Z)- (9CI) | C32H50O5 | 514.74 | | |
| 516 | 161099-36-1 | 13,30-Cyclodammar-24-en-26-oic acid, 7-(acetyloxy)-3-oxo-, (7α,17α,20S,24Z)- (9CI) | C32H48O5 | 512.72 | | |
| 517 | 161099-37-2 | Glicoricone | C21H20O6 | 368.3799 | | |
| 518 | 161099-38-3 | 3(2H)-Benzofuranone,2-[4,6-dihydroxy-2-methoxy-3-(3-methyl-2-butenyl)phenyl]-6-hydroxy- (9CI) | C20H20O6 | 356.37 | | |
| 519 | 161099-39-4 | 5H-Furo[3,2-b]xanthen-5-one, 7-(1,1-dimethyl-2-propen-1-yl)-6,9,11-trihydroxy- | C20H16O6 | 352.34 | | |
| 520 | 161099-40-7 | 5H-Furo[3,2-b]xanthen-5-one, 9-(1,1-dimethyl-2-propen-1-yl)-6,7,11-trihydroxy- | C20H16O6 | 352.34 | | |
| 521 | 161099-42-9 | Bidwillol A | C21H22O4 | 338.4 | | |
| 522 | 161099-43-0 | 6-Benzofuranol, 2-[4-hydroxy-2-methoxy-3-(3-methyl-2-buten-1-yl)phenyl]- | C20H20O4 | 324.37 | | |
| 523 | 161099-44-1 | 4H,8H-Benzo[1,2-b:3,4-b']dipyran-4-one, 3-(4-hydroxyphenyl)-8,8-dimethyl- | C20H16O4 | 320.34 | | |
| 524 | 161099-45-2 | 2(5H)-Furanone, 5-methyl-3-[(3R,13R)-3,8,13-trihydroxy-13-[(2R,5R)-tetrahydro-5-[(1R)-1-hydroxytridecyl]-2-furanyl]tridecyl]-, (5S)- | C35H64O7 | 596.88 | | |
| 525 | 161099-61-2 | Relaxin (baboon-A reduced) (9CI) | C116H192N32O33S4 | 2691.22 | | |
| 526 | 161099-62-3 | Relaxin (baboon B-reduced) (9CI) | C156H270N48O44S3 | 3618.3 | | |